|
Aug 1
|
Global Pharma Stocks Fall After Trump Demands Cuts in Drug Prices
|
|
Aug 1
|
Sodium Perborate Company Evaluation Report 2025 | Thermo Fisher, Merck KGaA, and Evonik Treibacher Lead with Strategic Expansions, Strong Distribution, and Eco-Friendly Innovation
|
|
Aug 1
|
European drugmakers fall after Trump raises stakes over US drug price cuts
|
|
Jul 25
|
MKKGY or STVN: Which Is the Better Value Stock Right Now?
|
|
Jul 24
|
MilliporeSigma and Washington University in St. Louis Sign MoU to Advance Scientific Collaboration
|
|
Jul 24
|
Merck KGaA (MKKGY) Upgraded to Strong Buy: Here's Why
|
|
Jul 24
|
Should Value Investors Buy Merck KGaA (MKKGY) Stock?
|
|
Jul 22
|
Sustainability Starts With the Product: MilliporeSigma's Commitment to Sustainability Through Greener Alternative Products
|
|
Jul 21
|
[Latest] Global Cardiac Tissue Engineering Market Size/Share Worth USD 2,943.92 Million by 2034 at a 16.65% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
|
|
Jul 21
|
Cell‑Based Assays Report 2025: Key Market Drivers, Tech Trends & Competitive Landscape to 2030
|
|
Jul 18
|
European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
|
|
Jul 18
|
Medical Filtration Company Benchmark Report 2025 | Merck KGaA, 3M, and Danaher Strengthen Medical Filtration Market Leadership Through Strategic Expansions, Spin-Offs, and Mergers
|
|
Jul 18
|
Microfiltration Membranes Company Evaluation Report 2024-2025 | Merck and Veolia Lead in Microfiltration Market with Strategic Moves
|
|
Jul 17
|
Sustainability Driving Global Innovation: Highlights From MilliporeSigma at Sustainability LIVE Chicago 2025
|
|
Jun 13
|
Citizens Financial, Merck, oil producers: Trending Tickers
|
|
May 30
|
ASCO25: Merck KGaA’s ADC shows safety and tolerability in colorectal cancer trial
|
|
Feb 11
|
Germany's Merck In Talks To Buy Cancer Drug Maker SpringWorks Therapeutics
|
|
Feb 11
|
Merck KGaA pursuing Springworks; BridgeBio wins EU drug OK
|
|
Feb 10
|
SpringWorks Stock Jumps More Than 30% on News of Possible Deal
|
|
Feb 10
|
Sector Update: Health Care Stocks Softer Late Afternoon
|